A detailed history of Adar1 Capital Management, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 10,000 shares of QURE stock, worth $128,400. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$128,400
% of portfolio
0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$4.54 - $17.73 $45,400 - $177,300
10,000 New
10,000 $177 Million
Q2 2024

Aug 13, 2024

BUY
$4.39 - $5.43 $4.08 Million - $5.05 Million
929,826 Added 317.51%
1,222,676 $5.48 Billion
Q1 2024

May 15, 2024

BUY
$4.82 - $6.93 $1.41 Million - $2.03 Million
292,850 New
292,850 $1.52 Billion

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $600M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.